Indian Pharma, and two other sectors to perform ‘better’ than global peers amid Trump tariffs, says Geojit’ Vinod Nair

Vinod Nair, Head of Research, Geojit Financial Services, sheds light on the geopolitical scenario amid the ongoing Trump tariff war, along with an outlook for the Q4 results and the Indian stock market. 

source https://www.livemint.com/market/stock-market-news/indian-pharma-and-two-other-sectors-to-perform-better-than-global-peers-amid-trump-tariffs-says-geojit-vinod-nair-11743958061473.html